Deerfield Special Situations Fund, L.P.

CIK 1354395 · last filed 2019-10-30

Deerfield Special Situations Fund, L.P. is a corporate insider who has filed 37 SEC Form 4 insider transactions across 20 companies since 2007. The most recent filing, for CABA, was dated Oct 30, 2019. Across all open-market trades the lifetime net is +$754.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $276.4M across reported positions. The firm reports its address in New York, NY. 278 SEC filings were submitted jointly with Deerfield Mgmt L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$276.39M

Companies

20

Total Filings

37

Lifetime Open-Market Net

$754.43M

Filer Profile

Reported Address
780 3RD AVENUE
37TH FLOOR
NEW YORK, NY 10017
Phone
(212) 551-1600
State of Incorporation
DE
Related Filers
Deerfield Mgmt L.P. — 278 joint filings, latest 2021-07-13
James E Flynn — 278 joint filings, latest 2021-07-13
DEERFIELD MANAGEMENT COMPANY, L.P. — 276 joint filings, latest 2021-07-13
Deerfield Special Situations Fund International LTD — 142 joint filings, latest 2013-07-18
DEERFIELD PARTNERS, L.P. — 94 joint filings, latest 2019-10-30
DEERFIELD PRIVATE DESIGN FUND L P — 49 joint filings, latest 2015-06-25
Deerfield Private Design International, L.P. — 48 joint filings, latest 2015-06-25
Deerfield Mgmt III, L.P. — 43 joint filings, latest 2019-03-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CABA 10%+ Owner 700,000 $2.73 $1.91M $53.90M 1 2019-10-30
Korro Bio, Inc. (FREQ) Delisted 10%+ Owner 9,457 $14.98 $141.7K $28.00M 1 2019-10-07
ACRS 3,159,165 $5.32 $16.81M -$19.84M 3 2019-07-01
XERS 10%+ Owner 873,520 $7.45 $6.51M -$11.93M 2 2019-02-07
CBIO 10%+ Owner 74,215 $19.41 $1.44M -$8.76M 1 2018-03-08
RYTM 10%+ Owner 468,505 $104.71 $49.06M $36.21M 1 2017-10-10
AXGN 10%+ Owner 3,000,000 $42.16 $126.48M -$2.74M 1 2016-07-21
EHTH 10%+ Owner 1,062,874 $0.93 $990.7K -$17.47M 1 2016-06-22
STREAMLINE HEALTH SOLUTIONS INC. (STRM) Delisted 10%+ Owner 125,033 $5.33 $666.8K -$1.95M 1 2015-12-17
CTMX 10%+ Owner 160,512 $3.29 $528.1K $45.00M 1 2015-10-14
ANTARES PHARMA, INC. (ATRS) Delisted 10%+ Owner 7,037,014 $5.59 $39.34M -$10.29M 1 2015-06-26
Auspex Pharmaceuticals, Inc. (ASPX) Delisted 10%+ Owner 953,286 $736.80M 2 2015-01-28
Dicerna Pharmaceuticals Inc (DRNA) Delisted 10%+ Owner 293,949 $38.22 $11.23M -$21.95M 1 2014-11-25
DUSA 10%+ Owner 1,278,032 $56.86 $72.67M -$4.36M 2 2011-03-22
NeuroMetrix, Inc. (NURO) Delisted 10%+ Owner 13 $4.58 $60 -$2.24M 1 2010-09-17
NxStage Medical, Inc. (NXTM) Delisted 10%+ Owner 1,231,478 -$9.89M 3 2009-12-15
NITROMED INC (NTMD) Delisted 10%+ Owner 3,580,090 $449.5K 4 2008-08-06
DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted 10%+ Owner $15.50 $0 2 2008-06-30
INSPIRE PHARMACEUTICALS INC (ISPH) Delisted 10%+ Owner 413,293 -$21.83M 1 2007-05-02
THIRD WAVE TECHNOLOGIES INC /WI (TWTI) Delisted 10%+ Owner 1,763,136 -$12.68M 3 2007-04-27

Recent Filings

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-10-30 CABA Mixed +11,399,542 $53.90M EDGAR
2019-10-07 Korro Bio, Inc. (FREQ) Delisted Mixed +8,620,038 $28.00M EDGAR
2019-07-01 ACRS Sell (S) −3,497,375 -$9.41M EDGAR
2019-06-25 ACRS Sell (S) −2,271,305 -$10.43M EDGAR
2019-02-07 XERS Sell (S) −88,842 -$1.33M EDGAR
2019-01-25 XERS Sell (S) −686,664 -$10.60M EDGAR
2019-01-18 ACRS Other (J) $0 EDGAR
2018-03-08 CBIO Sell (S) −287,112 -$8.76M EDGAR
2017-10-10 RYTM Mixed +5,622,060 $36.21M EDGAR
2016-07-21 AXGN Sell (S) −408,544 -$2.74M EDGAR
Showing 110 of 37
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.